NeoProgen
NeoProgen is a therapeutics company that focuses on advancing neonatal cardiac progenitor cells. The company specializes in the fields of biotechnology and cardiac therapy. NeoProgen was founded in 2018 and headquartered in Maryland, United States.
Domain
neoprogen.com
Country
United StatesIndustry
TherapeuticsEmployees
1-10
Last Funding
$1.5M
Founded
2018
No technologies detected yet for this company.
Frequently Asked Questions
What technologies does NeoProgen use?+
We have not yet detected technologies for NeoProgen.
What industry is NeoProgen in?+
NeoProgen operates in the Therapeutics industry.
Where is NeoProgen based?+
NeoProgen is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026